生物利用度
固体脂质纳米粒
没食子酸表没食子酸酯
药理学
体内分布
药物输送
药代动力学
药品
医学
体外
化学
纳米技术
生物化学
材料科学
抗氧化剂
多酚
作者
Harjeet Kaur,Baldeep Kumar,Amitava Chakrabarti,Bikash Medhi,Manish Modi,Bishan Dass Radotra,Ritu Aggarwal,Vivek Ranjan Sinha
标识
DOI:10.2174/1567201815666180926121104
摘要
BACKGROUND: Blood-brain permeability is the primary concern when dealing with the biodistribution of drugs to the brain in neurological diseases. OBJECTIVE: The purpose of the study is to develop the nanoformulation of Epigallocatechin gallate (EGCG) in order to improve its bioavailability and penetration into the brain. METHODS: EGCG loaded Solid Lipid Nanoparticles (SLNs) have been developed using microemulsification method and pharmacological assessments were performed. RESULTS: Surface morphology and micromeritics analysis showed the successful development of EGCG loaded solid lipid nanoparticles with an average size of 162.4 nm and spherical in shape. In vitro release studies indicated a consistent and slow drug release. Pharmacological evaluation of SLN-EGCG demonstrated a significant improvement in cerebral ischemia-induced memory impairment. CONCLUSION: The results indicate that the EGCG loaded SLNs provide a potential drug delivery system for improved delivery of EGCG to the brain, hence, enhancing its brain bioavailability.
科研通智能强力驱动
Strongly Powered by AbleSci AI